150 related articles for article (PubMed ID: 19061289)
1. Fascin determination in urothelial carcinomas of the urinary bladder: a marker of invasiveness.
Karasavvidou F; Barbanis S; Pappa D; Moutzouris G; Tzortzis V; Melekos MD; Koukoulis G
Arch Pathol Lab Med; 2008 Dec; 132(12):1912-5. PubMed ID: 19061289
[TBL] [Abstract][Full Text] [Related]
2. Fascin stain as a potential marker of invasiveness in carcinomas of the urinary bladder: a retrospective study with biopsy and cytology correlation.
McKnight R; Cohen C; Siddiqui MT
Diagn Cytopathol; 2011 Sep; 39(9):635-40. PubMed ID: 20949550
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of fascin-1 expression as a marker of invasion in urothelial carcinomas.
Sharma A; Badwal S; Dutta V; Basu A
Med J Armed Forces India; 2014 Apr; 70(2):139-43. PubMed ID: 24843202
[TBL] [Abstract][Full Text] [Related]
4. The role of fascin in migration and invasion of urothelial carcinoma of the bladder.
Bi JB; Zhu Y; Chen XL; Yu M; Zhang YX; Li BX; Sun JW; Shen HL; Kong CZ
Urol Int; 2013; 91(2):227-35. PubMed ID: 23428845
[TBL] [Abstract][Full Text] [Related]
5. Fascin-1 expression in papillary and invasive urothelial carcinomas of the urinary bladder.
Tong GX; Yee H; Chiriboga L; Hernandez O; Waisman J
Hum Pathol; 2005 Jul; 36(7):741-6. PubMed ID: 16084942
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical determination of ETS-1 oncoprotein expression in urothelial carcinomas of the urinary bladder.
Sari A; Calli A; Gorgel SN; Altinboga AA; Kara C; Dincel C; Cakalagaoglu F
Appl Immunohistochem Mol Morphol; 2012 Mar; 20(2):153-8. PubMed ID: 21623185
[TBL] [Abstract][Full Text] [Related]
7. IMP3 expression in urothelial carcinomas of the urinary bladder.
Ozdemir NO; Türk NS; Düzcan E
Turk Patoloji Derg; 2011 Jan; 27(1):31-7. PubMed ID: 21469424
[TBL] [Abstract][Full Text] [Related]
8. Does the expression of fascin-1 and tumor subclassification help to assess the risk of recurrence and progression in t1 urothelial urinary bladder carcinoma?
Soukup V; Babjuk M; Dusková J; Pesl M; Szakáczová M; Zámecník L; Dvorácek J
Urol Int; 2008; 80(4):413-8. PubMed ID: 18587253
[TBL] [Abstract][Full Text] [Related]
9. Fascin is a predictor for invasiveness and recurrence of urothelial carcinoma of bladder.
Bi J; Chen X; Zhang Y; Li B; Sun J; Shen H; Kong C
Urol Oncol; 2012 Sep; 30(5):688-94. PubMed ID: 20888270
[TBL] [Abstract][Full Text] [Related]
10. CD 10 expression intensity in various grades and stages of urothelial carcinoma of urinary bladder.
Atique M; Abbasi MS; Jamal S; Khadim MT; Akhtar F; Jamal N
J Coll Physicians Surg Pak; 2014 May; 24(5):351-5. PubMed ID: 24848395
[TBL] [Abstract][Full Text] [Related]
11. Fascin as an identifier of metastatic urothelial carcinoma: A retrospective study of fine-needle aspiration cell blocks and histologic tissue microarrays.
Vogt AP; Cohen C; Siddiqui MT
Diagn Cytopathol; 2012 Oct; 40(10):882-6. PubMed ID: 21433004
[TBL] [Abstract][Full Text] [Related]
12. Fascin expression in colorectal carcinomas.
Ozerhan IH; Ersoz N; Onguru O; Ozturk M; Kurt B; Cetiner S
Clinics (Sao Paulo); 2010 Feb; 65(2):157-64. PubMed ID: 20186299
[TBL] [Abstract][Full Text] [Related]
13. DDR2 overexpression in urothelial carcinoma indicates an unfavorable prognosis: a large cohort study.
Tsai MC; Li WM; Huang CN; Ke HL; Li CC; Yeh HC; Chan TC; Liang PI; Yeh BW; Wu WJ; Lim SW; Li CF
Oncotarget; 2016 Nov; 7(48):78918-78931. PubMed ID: 27793038
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of fascin expression in extrahepatic bile duct carcinomas.
Won KY; Kim GY; Lim SJ; Park YK; Kim YW
Pathol Res Pract; 2009; 205(11):742-8. PubMed ID: 19556073
[TBL] [Abstract][Full Text] [Related]
15. Decreased RECK and Increased EMMPRIN expression in urothelial carcinoma of the bladder are associated with tumor aggressiveness.
Wittschieber D; Stenzinger A; Klauschen F; Stephan C; Jung K; Erbersdobler A; Rabien A
Pathobiology; 2011; 78(3):123-31. PubMed ID: 21613799
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of p63, p53 and MIB-1 in urinary bladder carcinoma. A tissue microarray study of 158 cases.
Compérat E; Camparo P; Haus R; Chartier-Kastler E; Bart S; Delcourt A; Houlgatte A; François R; Capron F; Vieillefond A
Virchows Arch; 2006 Mar; 448(3):319-24. PubMed ID: 16283378
[TBL] [Abstract][Full Text] [Related]
17. High expression of Notch ligand Jagged2 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.
Li W; Liu M; Feng Y; Huang YF; Xu YF; Che JP; Wang GC; Zheng JH
Int J Clin Exp Pathol; 2013; 6(11):2430-40. PubMed ID: 24228105
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of p63, p53 in urinary bladder carcinoma.
Koyuncuer A
Indian J Pathol Microbiol; 2013; 56(1):10-5. PubMed ID: 23924551
[TBL] [Abstract][Full Text] [Related]
19. Correlation of pathological grade and tumor stage of urothelial carcinomas with CD109 expression.
Hagikura M; Murakumo Y; Hasegawa M; Jijiwa M; Hagiwara S; Mii S; Hagikura S; Matsukawa Y; Yoshino Y; Hattori R; Wakai K; Nakamura S; Gotoh M; Takahashi M
Pathol Int; 2010 Nov; 60(11):735-43. PubMed ID: 20946523
[TBL] [Abstract][Full Text] [Related]
20. E-cadherin expression in invasive urothelial carcinoma.
Sun W; Herrera GA
Ann Diagn Pathol; 2004 Feb; 8(1):17-22. PubMed ID: 15129905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]